Rooted Apothecary is accused of using its online store and social media sites to make unfounded claims about its CBD products and other products that are unlawfully marketed as dietary supplements.
The store posted online that one of its products could help with “skin problems such as acne, autism, ADHD, and even cancer.” It also said “children can use high amounts of CBD safely and without any risk.”
The FDA said it is especially concerned when companies market unproven CBD products for use in “vulnerable populations like infants and children.”
Rooted Apothecary also claimed its products could treat teething pain and earaches in infants as well as Parkinson’s.
“FDA continues to be concerned about the proliferation of products claiming to contain CBD that are marketed for therapeutic or medical uses that have not been approved by the agency,” the FDA wrote.
The agency requested that Rooted Apothecary responds with a corrective action plan within 15 business days. Failure to do so could result in legal action, the FDA warned.
Read the full news release here.
More articles on pharmacy:
Novant Health leaders talk Walgreens partnership goals for 2020
Sanofi recalls heartburn drug over cancer risks
Cheating scandal prompts California to invalidate pharmacist test scores
